Booth, C;
Gaspar, HB;
Thrasher, AJ;
(2016)
Treating Immunodeficiency through HSC Gene Therapy.
Trends In Molecular Medicine
, 22
(4)
pp. 317-327.
10.1016/j.molmed.2016.02.002.
Preview |
Text (Article)
Booth_Treating Immunodeficiency through HSC Gene Therapy.pdf Download (571kB) | Preview |
Preview |
Text (Figure 1)
Booth_Treating Immunodeficiency through HSC Gene Therapy Figure 1.pdf Download (223kB) | Preview |
Preview |
Text (Figure 2)
Booth_Treating Immunodeficiency through HSC Gene Therapy Figure 2.pdf Download (225kB) | Preview |
Abstract
Haematopoietic stem cell (HSC) gene therapy has been successfully employed as a therapeutic option to treat specific inherited immune deficiencies, including severe combined immune deficiencies (SCID) over the past two decades. Initial clinical trials using first-generation gamma-retroviral vectors to transfer corrective DNA demonstrated clinical benefit for patients, but were associated with leukemogenesis in a number of cases. Safer vectors have since been developed, affording comparable efficacy with an improved biosafety profile. These vectors are now in Phase I/II clinical trials for a number of immune disorders with more preclinical studies underway. Targeted gene editing allowing precise DNA correction via platforms such as ZFNs, TALENs and CRISPR/Cas9 may now offer promising strategies to improve the safety and efficacy of gene therapy in the future.
| Type: | Article |
|---|---|
| Title: | Treating Immunodeficiency through HSC Gene Therapy |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.molmed.2016.02.002 |
| Publisher version: | http://dx.doi.org/10.1016/j.molmed.2016.02.002 |
| Language: | English |
| Additional information: | Copyright © 2016. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0. Access may be initially restricted by the publisher. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Biochemistry & Molecular Biology, Cell Biology, Medicine, Research & Experimental, Research & Experimental Medicine, Chronic Granulomatous-disease, Leukocyte Adhesion Deficiency, Hematopoietic Stem-cells, Adenosine-deaminase-deficiency, Wiskott-aldrich Syndrome, Lentiviral Vector, Lymphoproliferative Disease, Murine Model, X-cgd, Mice |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1481142 |
Archive Staff Only
 |
View Item |
